Application Nr Approved Date Route Status External Links
NDA203049 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Argatroban Is A Direct Thrombin Inhibitor Indicated: For Prophylaxis Or Treatment Of Thrombosis In Adult Patients With Heparin-Induced Thrombocytopenia (Hit). ( 1.1 ) As An Anticoagulant In Adult Patients With Or At Risk For Hit Undergoing Percutaneous Coronary Intervention (Pci). ( 1.2 ) 1.1 Heparin-Induced Thrombocytopenia Argatroban Injection Is Indicated For Prophylaxis Or Treatment Of Thrombosis In Adult Patients With Heparin-Induced Thrombocytopenia (Hit). 1.2 Percutaneous Coronary Intervention Argatroban Injection Is Indicated As An Anticoagulant In Adult Patients With Or At Risk For Hit Undergoing Percutaneous Coronary Intervention (Pci).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Argatroban ARGATROBAN ZINC3917722

Comments